Resultados de la búsqueda 171-180 of 388 for Isotope

  1. Oncología (médica) - Ensayos clínicos

    Scottsdale/Phoenix, Ariz., Rochester, Minn. This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor ...

  2. Oncología (médica) - Ensayos clínicos

    Patients with known EGFR (Epidermal growth factor receptor) tyrosine kinase (TK) activating mutations and anaplastic lymphoma kinase (ALK) rearrangements are ...

  3. Oncología (médica) - Ensayos clínicos

    This study aims to demonstrate that the efficacy of treatment with selumetinib as measured by event-free survival (EFS) is non-inferior compared to ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. This study aims to identify candidate High Grade Serous Cancer (HGSC) early detection and chemotherapy treatment response biomarkers. For the ...

  5. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate immune profile of Acute Myeloid Leukemia (AML) patients receiving Venetoclax plus Azacitidine induction chemotherapy. A ...

  6. Hematología - Ensayos clínicos

    The purpose of this study is to compare the effects (good and bad) on patients with prostate cancer by comparing the standard dose of radiation therapy (44 ...

  7. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate the feasibility of molecular characterization based on tumor mutational burden (TMB) for participant stratification, as ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Chemotherapy drugs, such as cisplatin, carboplatin, and gemcitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate how well combination chemotherapy works in treating patients with newly diagnosed stage II-IV diffuse anaplastic Wilms ...

  10. Oncología (médica) - Ensayos clínicos

    This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has ...